Paysign, Inc.: directors' dealings · United States · SEC (Form 4)

About Paysign, Inc.

Paysign, Inc. is a United States-based company listed on the NASDAQ market (United States) and focused on prepaid card payment solutions and integrated payment processing services. Headquartered in Henderson, Nevada, the company was incorporated on August 24, 1995. For French-speaking investors, Paysign should be viewed less as a traditional bank and more as a niche fintech and payments infrastructure provider: it designs, launches, and operates physical and virtual prepaid card programs, together with the related processing stack, for clients that need fast disbursement, traceability, and strong compliance controls. The company’s business model is primarily B2B/B2B2C. Historically, Paysign has served corporate, consumer, and government customers with prepaid card products and processing services. More recently, management has emphasized two strategic growth engines: patient affordability programs for the pharmaceutical industry and donor compensation solutions for plasma collection centers. This verticalized approach places Paysign inside regulated workflows where payment accuracy, operational reliability, and user experience matter materially. Paysign positions itself as a full-service partner, able to handle program design, card issuance, transaction processing, operations, and certain support functions. From a competitive standpoint, Paysign operates in a fragmented market that includes large payment processors, card issuers, gift-card specialists, and fintech vendors focused on specific verticals. Its competitive edge is more about specialization than sheer scale: the company targets end markets where customized program architecture and deep operational integration create stickiness. Management also highlights a portfolio of millions of prepaid cards, which suggests a meaningful installed base within its niche. Geographically, the business is mainly concentrated in the United States, although its services may support customers with broader operating footprints. The company remains headquartered in Henderson, Nevada, and reported approximately 226 employees and independent contractors at year-end 2025. Recent developments are important for the investment case. On March 24, 2026, Paysign reported full-year 2025 revenue of $82.0 million, up 40.5% year over year, with margin expansion driven by an improved mix. The company also reported growth in plasma center count and active patient affordability programs, reinforcing the momentum in its highest-growth verticals. In addition, Paysign continues to appear in a steady flow of SEC Form 4 insider transaction filings, which keeps the market attentive to changes in insider ownership and trading activity.